State of Nevada Adopts ODG Drug Formulary to Support Evidence-Based Care in Workers' Compensation

Bipartisan legislation makes Nevada the thirteenth state to adopt an ODG tool for workers' comp claims

CARSON CITY, Nev., July 15, 2025 /PRNewswire/ -- ODG by MCG, an MCG Health company and part of the Hearst Health network, announces the State of Nevada's recent passage of bipartisan legislation requiring its Division of Industrial Relations (DIR) to officially adopt the ODG Drug Formulary. The ODG Drug Formulary is a list of medications used in workers' compensation cases and is derived from evidence-based recommendations in the widely used ODG Treatment Guidelines. Nevada is the thirteenth U.S. state to implement an ODG solution with the goal of guiding safe and effective return-to-work practices for injured workers.

The formulary adoption was part of Nevada Senate Bill 317 which introduces significant changes to the Silver State's workers' compensation system. The bill was signed into law by Governor Joe Lombardo (R) on June 10, 2025, after overwhelming passage in the Democrat-controlled State Assembly (42-0) and State Senate (20-0-1). The new legislation mandates the Nevada Division of Industrial Relations (DIR) to implement the ODG Drug Formulary by January 1, 2027, marking a notable shift to a closed drug formulary system. The evidence-based approach is designed to promote safer medical practices while achieving long-term cost containment. To ensure an effective transition, coverage for non-formulary drugs will continue until January 1, 2028.

"The adoption of the ODG Drug Formulary represents a commitment to high-value care for workers in Nevada," said Troy J. Prevot, MBA, PA-C, ODG by MCG's Associate Vice President of Strategic Solutions and Regulatory Affairs. "This bipartisan legislation demonstrates the state's focus on balancing quality healthcare with fiscal responsibility, benefitting both employers and employees alike."

To help introduce the ODG Drug Formulary to workers' compensation professionals in the state, Mr. Prevot will join ODG's Director, Product Management, Pamela Bloom-Pugliese, BSN, RN, to present the session, "The Use of the ODG Drug Formulary in the Nevada Workers' Compensation System," at the 13th Annual Nevada Workers' Compensation Educational Conference (September 11-12, 2025) at the Palace Station Hotel and Casino in Las Vegas.

The ODG Drug Formulary is reviewed quarterly by clinical editors, ensuring it stays aligned with the latest scientific literature, evolving drug availability, and cost considerations. Additional information about the ODG Drug Formulary can be found at www.mcg.com/odg/workers-comp-guidelines/workers-compensation-solutions/drug-formulary/.

About ODG by MCG

ODG by MCG, an MCG Health company, (www.mcg.com/odg) supports workers' comp, disability, and auto liability claims and medical management with unbiased, evidence-based guidelines that unite payers, providers, and employers in their efforts to return people confidently and effectively to health. ODG clinical guidelines and analytical tools are designed to improve and benchmark return-to-work performance, facilitate quality care while limiting inappropriate utilization, assess claim risk for interventional triage, and set reserves based on industry data.

About MCG Health

MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG's artificial intelligence and technology, infused with clinical expertise, enables its clients to prioritize and simplify their work. MCG's world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit www.mcg.com.

Contact
Arri Stewart
MCG Health
Tel: (206) 389-5405
[email protected]

SOURCE MCG Health